Skip to content

QDEM – branded generic medicines

qdem pharmaceutical logo

Qdem Pharmaceuticals Limited is a wholly owned subsidiary of Napp Pharmaceuticals Limited providing branded generic medicines to the NHS.

Active IngredientApplicationActive ingredientSummary of Product CharacteristicsPatient Information LeafletPrice
Butec 5 microgram/hour Transdermal PatchbuprenorphineView SMPCView PIL£7.92
Butec 10 microgram/hour Transdermal PatchbuprenorphineView SMPCView PIL£14.20
Butec 15 microgram/hourTransdermal PatchbuprenorphineView SMPCView PIL£22.12
Butec 20 microgram/hourTransdermal PatchbuprenorphineView SMPCView PIL£25.86
Longtec 5 mg Prolonged

Release Tabletsoxycodone
hydrochloride		View SMPCView PIL£4 .69
Longtec 10 mg ProlongedRelease Tabletsoxycodone
hydrochloride		View SMPCView PIL£9.39
Longtec 15 mg ProlongedRelease Tabletsoxycodone
hydrochloride		View SMPCView PIL£14.30
Longtec 20 mg ProlongedRelease Tabletsoxycodone
hydrochloride		View SMPCView PIL£18.78
Longtec 30 mg ProlongedRelease Tabletsoxycodone
hydrochloride		View SMPCView PIL£28.58
Longtec 40 mg ProlongedRelease Tabletsoxycodone
hydrochloride		View SMPCView PIL£37.57
Longtec 60 mg ProlongedRelease Tabletsoxycodone
hydrochloride		View SMPCView PIL£57.18
Longtec 80 mg ProlongedRelease Tabletsoxycodone
hydrochloride		View SMPCView PIL£75.14
Longtec 120 mg ProlongedRelease Tabletsoxycodone
hydrochloride		View SMPCView PIL£114.38
Shortec 5 mgHard Capsulesoxycodone
hydrochloride		View SMPCView PIL£6.86
Shortec 10 mgHard Capsulesoxycodone
hydrochloride		View SMPCView PIL£13.72
Shortec 20 mgHard Capsulesoxycodone
hydrochloride		View SMPCView PIL£27.43
Shortec Injection 10 mg/mlSolution for injection or infusionoxycodone
hydrochloride		View SMPCView PIL£13.60
Shortec Injection 50 mg/mlSolution for injection or infusionoxycodone
hydrochloride		View SMPCView PIL£59.59

Medical Information

For enquiries about our products, please contact our Medical Information service on 01223 426929 or by email at medicalinformationUKQdem@qdemstagingsite.co.uk.

Please note, our services are only available to UK-based healthcare professionals. Enquiries are monitored between 8:30am to 5:00pm, Monday to Friday. For urgent medical enquiries outside of these hours please call 01223 426929.

Reporting adverse events

 

UK Healthcare professional

Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk/. Adverse events should also be reported to Napp Pharmaceuticals Limited at drugsafetyUKandROI@mundipharma.com.

A patient or a member of the general public

If you get any side-effects, talk to your doctor, nurse or pharmacist. This includes any possible side-effects not listed in the package leaflet. You can also report side-effects directly via the Yellow Card scheme at www.yellowcard.mhra.gov.uk/. By reporting side-effects you can help provide more information on the safety of this medicine.

General Enquiries

For all other enquiries, including recruitment and business development, please contact:

Qdem Pharmaceuticals Limited
Unit 198
Cambridge Science Park
Milton Road
Cambridge
CB4 0AB*

*SatNav users please use postcode CB4 0GW

© 2024 NAPP PHARMACEUTICALS LIMITED. DOP September 2022 UK-CORP-2200003

Opioid Charter

For Mundipharma’s Charter on the responsible medical use of opioid analgesics in pain management click here.

Opioid Safety Statement

“Attention should be given as the use of opioids has a risk of addiction, misuse and abuse. Therefore, appropriate assessment and monitoring is a requirement at initiation, maintenance and tapering down of opioid therapy.”